EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HL156A, an AMP-Activated Protein Kinase Activator, Inhibits Cyst Growth in Autosomal Dominant Polycystic Kidney Disease

Sujung Seo, Hyunho Kim, Jung-Taek Hwang, Jin Eop Kim, Jisu Kim, Sohyun Jeon, Young-Jin Song, Kwang-Ho Choi, Gwangeon Sim, Myunkyu Cho, Jong-Woo Yoon iD, Hyunsuk Kim

Biomolecules · 2024

DOI: 10.3390/biom14070806 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Sujung Seo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hallym University Medical Center, Chuncheon Sacred Heart Hospital, Chuncheon 24253, Republic of Korea. Hauptthemen laut MEDLINE: Polycystic Kidney, Autosomal Dominant, AMP-Activated Protein Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, KOREAN NEPHROLOGY RESEARCH FOUNDATION.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Autosomal dominant polycystic kidney disease (ADPKD) is the most prevalent genetic kidney disorder. While metformin has demonstrated the ability to inhibit cyst growth in animal models of ADPKD via activation of adenosine monophosphate-activated protein kinase (AMPK), its effectiveness in humans is limited due to its low potency. This study explored the impact of HL156A, a new and more potent AMPK activator, in a mouse model of ADPKD.

Methods

To investigate whether HL156A inhibits the proliferation of renal cyst cells in ADPKD in vitro, exogenous human telomerase reverse transcriptase (hTERT)-immortalized renal cyst cells from ADPKD patients were treated with HL156A, and an MTT (dimethylthiazol-diphenyltetrazolium bromide) assay was performed. To assess the cyst-inhibitory effect of HL156A in vivo, we generated Pkd1 conditional knockout (KO) mice with aquaporin 2 (AQP2)-Cre, which selectively expresses Cre recombinase in the collecting duct. The effectiveness of HL156A in inhibiting cyst growth and improving renal function was confirmed by measuring the number of cysts and blood urea nitrogen (BUN) levels in the collecting duct-specific Pkd1 KO mice.

Results

When cyst cells were treated with up to 20 µM of metformin or HL156A, HL156A reduced cell viability by 25% starting at a concentration of 5 µM, whereas metformin showed no effect. When AQP2-Cre male mice were crossed with Pkd1flox/flox female mice, and when AQP2-Cre female mice were crossed with Pkd1flox/flox male mice, the number of litters produced by both groups was comparable. In collecting duct-specific Pkd1 KO mice, HL156A was found to inhibit cyst growth, reducing both the number and size of cysts. Furthermore, it was confirmed that kidney function improved as HL156A treatment led to a reduction in elevated BUN levels. Lastly, it was observed that the increase in AMPK phosphorylation induced by HL156A decreased ERK phosphorylation and α-SMA expression.

Conclusion

HL156A has potential as a drug that can restore kidney function in ADPKD patients by inhibiting cyst growth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Kidney, Autosomal DominantAMP-Activated Protein KinasesAnimalsMiceHumansMice, KnockoutCell ProliferationMaleDisease Models, AnimalCysts

Stichwörter der Autor:innen

ADPKDAMPK activatorHL156Acollecting duct-specific Pkd1 KO mice

Substanzen

AMP-Activated Protein Kinases

Autor:innen und Institutionen

  • Department of Internal Medicine, Hallym University Medical Center, Chuncheon Sacred Heart Hospital, Chuncheon 24253, Republic of Korea.
  • Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul 03080, Republic of Korea.

ORCID-Profile: Jong-Woo Yoon

Förderung

  • National Research Foundation of Korea
  • KOREAN NEPHROLOGY RESEARCH FOUNDATION

Zitieren

APA

Seo, S., Kim, H., Hwang, J. T., Kim, J. E., Kim, J., Jeon, S., Song, Y. J., Choi, K. H., Sim, G., Cho, M., Yoon, J. W., & Kim, H. (2024). HL156A, an AMP-Activated Protein Kinase Activator, Inhibits Cyst Growth in Autosomal Dominant Polycystic Kidney Disease. Biomolecules. https://doi.org/10.3390/biom14070806

Vancouver

Seo S, Kim H, Hwang JT, Kim JE, Kim J, Jeon S, et al. HL156A, an AMP-Activated Protein Kinase Activator, Inhibits Cyst Growth in Autosomal Dominant Polycystic Kidney Disease. Biomolecules. 2024. doi:10.3390/biom14070806

BibTeX
@article{Seo2024,
  author = {Seo, Sujung and Kim, Hyunho and Hwang, Jung-Taek and Kim, Jin Eop and Kim, Jisu and Jeon, Sohyun and Song, Young-Jin and Choi, Kwang-Ho and Sim, Gwangeon and Cho, Myunkyu and Yoon, Jong-Woo and Kim, Hyunsuk},
  title = {HL156A, an AMP-Activated Protein Kinase Activator, Inhibits Cyst Growth in Autosomal Dominant Polycystic Kidney Disease},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14070806}
}
Kostenlos starten →